The biologics fill finish manufacturing market offers key opportunities through outsourcing trends, technological advancements enhancing efficiency, and growing demand for biologics, particularly in ...

The aseptic fill finish manufacturing market is witnessing growth opportunities driven by the rising demand for biologics, vaccines, and sterile injectables. Outsourcing to CMOs accelerates growth by ...

LEVERKUSEN, Germany, Nov. 13, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it ...

Becton, Dickinson and Company BDX, popularly known as BD, has announced the commercial release of the BD Neopak XtraFlow Glass Prefillable Syringe, expanding its Neopak Glass Prefillable Syringe ...

Key market opportunities in the prefilled syringe fill finish sector include the rise in demand for self-medication, outsourcing of fill/finish operations to address technical challenges, and ...

FRANKLIN LAKES, N.J., Jan. 13, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million investment to expand its ...

The "Prefilled Syringe Fill Finish Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapeutic Area, Type of Syringe Barrel Material, Number of Barrel ...

WUXI, China, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing ...

Japan’s AGC Biologics and contract manufacturing specialist BioConnection are teaming up to offer drug development and production services to the biopharma industry and to provide an alternative to ...

(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in the prefilled syringe fill finish sector include the rise in demand for self-medication, outsourcing of fill/finish operations to address ...